LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Tuberculosis disease in immunocompromised children and adolescents: a pTBnet multi-centre case-control study.

    Rodríguez-Molino, Paula / Tebruegge, Marc / Noguera-Julian, Antoni / Neth, Olaf / Fidler, Katy / Brinkmann, Folke / Sainz, Talia / Ivaskeviciene, Inga / Ritz, Nicole / Brito, Maria Joao / Milheiro Silva, Tiago / Chechenieva, Vira / Serdiuk, Maryna / Lancella, Laura / Russo, Cristina / Soler-García, Aleix / Navarro, Maria Luisa / Krueger, Renate / Feiterna-Sperling, Cornelia /
    Starshinova, Anna / Hiteva, Antonina / Hoffmann, Anna / Kalibatas, Paulius / Lo Vecchio, Andrea / Scarano, Sara Maria / Bustillo, Matilde / Blázquez Gamero, Daniel / Espiau, María / Buonsenso, Danilo / Falcón, Lola / Turnbull, Louise / Colino, Elena / Rueda, Santiago / Buxbaum, Charlotte / Carazo, Begoña / Alvarez, Cristina / Dapena, Marta / Piqueras, Anabel / Velizarova, Svetlana / Ozere, Iveta / Götzinger, Florian / Pareja, Marta / Garrote Llanos, Maria Isabel / Soto, Beatriz / Rodríguez Martín, Sonia / Korta, Jose Javier / Pérez-Gorricho, Beatriz / Herranz, Mercedes / Hernández-Bartolomé, Ángel / Díaz-Almirón, Mariana / Kohns Vasconcelos, Malte / Ferreras-Antolín, Laura / Santiago-García, Begoña

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2024  

    Abstract: Background: In high-resource settings the survival of immunocompromised (IC) children has increased and immunosuppressive therapies are increasingly being used. This study aimed to determine the clinical characteristics, performance of diagnostic tools ... ...

    Abstract Background: In high-resource settings the survival of immunocompromised (IC) children has increased and immunosuppressive therapies are increasingly being used. This study aimed to determine the clinical characteristics, performance of diagnostic tools and outcome of IC children with TB in Europe.
    Methods: Multicentre, matched case-control study within the Paediatric Tuberculosis Network European Trials Group (ptbnet), capturing TB cases <18 years diagnosed 2000-2020.
    Results: 417 TB cases were included, comprising 139 children with IC (HIV, inborn errors of immunity, drug-induced immunosuppression and other immunocompromising conditions) and 278 non-IC children as controls. Non-respiratory TB was more frequent among cases than controls (32.4% vs. 21.2%; p = 0.013). IC patients had an increased likelihood of presenting with severe disease (57.6% vs. 38.5%; p < 0.001; OR [95% CI]: 2.073 [1.37-3.13]). Children with IC had higher rates of false-negative tuberculin skin test (31.9% vs. 6.0%; p < 0.001) and QuantiFERON-TB Gold assay (30.0% vs. 7.3%; p < 0.001) results at diagnosis. Overall, the microbiological confirmation rate was similar in IC and non-IC cases (58.3% vs. 49.3%; p = 0.083). Although the mortality in IC children was <1%, the rate of long-term sequelae was significantly higher than in non-IC cases (14.8% vs. 6.1%; p = 0.004).
    Conclusions: IC children with TB disease in Europe have increased rates of non-respiratory TB, severe disease, and long-term sequelae. Immune-based TB tests have poor sensitivity in those children. Future research should focus on developing improved immunological TB tests that perform better in IC patients, and determining the reasons for the increased risk of long-term sequelae, with the aim to design preventive management strategies.
    Language English
    Publishing date 2024-04-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciae158
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Performance of QuantiFERON-

    Soler-Garcia, Aleix / Gamell, Anna / Pérez-Porcuna, Tomàs / Soriano-Arandes, Antonio / Santiago, Begoña / Tórtola, Teresa / Ruiz-Serrano, María Jesús / Korta Murua, José Javier / Bustillo-Alonso, Matilde / Garrote-Llanos, María Isabel / Rodríguez-Molino, Paula / Piqueras, Ana Isabel / Tagarro, Alfredo / Monsonís, Manuel / Tebruegge, Marc / Noguera-Julian, Antoni

    Thorax

    2021  Volume 77, Issue 12, Page(s) 1193–1201

    Abstract: Introduction: The QuantiFERON-: Methods: Cross-sectional, multicentre study at healthcare institutions participating in the Spanish Paediatric TB Research Network, including patients <18 years who had a QFT-Plus performed between September 2016 and ... ...

    Abstract Introduction: The QuantiFERON-
    Methods: Cross-sectional, multicentre study at healthcare institutions participating in the Spanish Paediatric TB Research Network, including patients <18 years who had a QFT-Plus performed between September 2016 and June 2020.
    Results: Of 1726 patients (52.8% male, median age: 8.4 years), 260 (15.1%) underwent testing during contact tracing, 288 (16.7%) on clinical/radiological suspicion of tuberculosis disease (TBD), 649 (37.6%) during new-entrant migrant screening and 529 (30.6%) prior to initiation of immunosuppressive treatment. Overall, the sensitivity of QFT-Plus for TBD (n=189) and for latent tuberculosis infection (LTBI, n=195) was 83.6% and 68.2%, respectively. The agreement between QFT-Plus TB1 and TB2 antigen tubes was excellent (98.9%, κ=0.961). Only five (2.5%) patients with TBD had discordance between TB1 and TB2 results (TB1+/TB2-, n=2; TB1-/TB2+, n=3). Indeterminate assay results (n=54, 3.1%) were associated with young age, lymphopenia and elevated C reactive protein concentrations.
    Conclusions: Our non-comparative study indicates that QFT-Plus does not have greater sensitivity than previous-generation IGRAs in children in both TBD and LTBI. In TBD, the addition of the second antigen tube, TB2, does not enhance the assay's performance substantially.
    MeSH term(s) Humans ; Male ; Adolescent ; Child ; Female ; Cross-Sectional Studies ; Mycobacterium tuberculosis ; Interferon-gamma Release Tests/methods ; Latent Tuberculosis/diagnosis ; Tuberculosis/diagnosis ; Tuberculin Test/methods
    Language English
    Publishing date 2021-12-07
    Publishing country England
    Document type Multicenter Study ; Journal Article
    ZDB-ID 204353-1
    ISSN 1468-3296 ; 0040-6376
    ISSN (online) 1468-3296
    ISSN 0040-6376
    DOI 10.1136/thoraxjnl-2021-217592
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top